GLP-1RAs showed significantly more reduction of cardiovascular endpoints than other second- or third-line glucose-lowering medications
"I was like, 'I don't want no soda
Its usually recommended to have someone else perform the injection in this area, as it can be hard to see and reach properly on your own
Cost-benefit at scale: If millions use retatrutide for years, do the cardiovascular and diabetes prevention benefits outweigh the side effect burden and $15,00018,000 annual cost
Hepatic fat accumulation is one of the most predictable downstream consequences of insulin resistance, and its reduction is directly linked to improvements in cardiovascular risk and all-cause mortality
The list even features 8 mg formulations, that are clinically recognized as a suitable dose for weight reduction across various patient base